| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.007 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.084 | 0.008 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.009 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |